EXPRESSION OF CYCLOOXYGENASE-2 IN CHOROIDAL NEOVASCULAR MEMBRANES FROM AGE-RELATED MACULAR DEGENERATION PATIENTS : RETINA

Secondary Logo

Journal Logo

Original Articles

EXPRESSION OF CYCLOOXYGENASE-2 IN CHOROIDAL NEOVASCULAR MEMBRANES FROM AGE-RELATED MACULAR DEGENERATION PATIENTS

MALONEY, SHAWN C. MSc; FERNANDES, BRUNO F. MD, PhD; CASTIGLIONE, ENZO MD; ANTECKA, EMILIA MD, PhD; MARTINS, CLAUDIA MD; MARSHALL, JEAN-CLAUDE PhD; DI CESARE, SEBASTIAN MSc; LOGAN, PATRICK MSc; BURNIER, MIGUEL N. Jr MD, PhD

Author Information
Retina 29(2):p 176-180, February 2009. | DOI: 10.1097/IAE.0b013e3181884fa6

Purpose: 

The objective of this study was to investigate the expression of cyclooxygenase (COX)-2 in human choroidal neovascular membranes.

Methods: 

Paraffin-embedded sections of choroidal neovascular membranes excised from 16 patients with wet age-related macular degeneration were used for this study. Sections were subjected to immunohistochemistry using a monoclonal mouse antihuman COX-2 antibody. Staining was classified as either negative or positive in retinal pigment epithelial cells, vascular endothelial cells, and fibroblasts. Serial sections were stained for vimentin expression to confirm tissue antigenicity.

Results: 

Eleven of 16 (69%) choroidal neovascular membranes stained positive for COX-2 in retinal pigment epithelial cells, with 6 (38%) of these also expressing COX-2 in vascular endothelial cells and 6 (38%) in fibroblasts. None of the sections that were negative for COX-2 in the retinal pigment epithelial cells showed COX-2 expression in the other cell types assessed. There was a statistically significant difference (P = 0.0097) in the mean ages between the COX-2 positive group (65.6 years) and COX-2 negative group (76.8 years) as determined by a two-tailed, unpaired Student’s t-test.

Conclusion: 

The expression of COX-2 in human choroidal neovascular membranes suggests a possible role for this modulator in age-related macular degeneration pathogenesis. The age-dependent expression observed is novel and warrants further investigation.

© The Ophthalmic Communications Society, Inc.

You can read the full text of this article if you:

Access through Ovid